237 related articles for article (PubMed ID: 33400625)
1. Long-term Oncologic Outcomes of 1188 Tis-T2 Glottic Cancers Treated by Transoral Laser Microsurgery.
Piazza C; Paderno A; Del Bon F; Lancini D; Fior M; Berretti G; Bosio P; Deganello A; Peretti G
Otolaryngol Head Neck Surg; 2021 Aug; 165(2):321-328. PubMed ID: 33400625
[TBL] [Abstract][Full Text] [Related]
2. Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up.
De Seta D; Campo F; D'Aguanno V; Ralli M; Greco A; Russo FY; de Vincentiis M
Lasers Med Sci; 2021 Apr; 36(3):507-512. PubMed ID: 32472425
[TBL] [Abstract][Full Text] [Related]
3. Oncological and Surgical Outcomes of Patients Treated by Transoral CO
Hans S; Crevier-Buchman L; Circiu M; Idrissi YC; Distinguin L; de Mones E; Brasnu D; Lechien JR
Ear Nose Throat J; 2021 Feb; 100(1_suppl):33S-37S. PubMed ID: 32204623
[TBL] [Abstract][Full Text] [Related]
4. Oncologic results and quality of life in patients with T3 glottic cancer after transoral laser microsurgery.
Chien PJ; Hung LT; Wang LW; Yang MH; Chu PY
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2983-2992. PubMed ID: 33403435
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of surgical margin status in patients with early glottic cancer (Tis-T2) treated with transoral CO
Hendriksma M; Montagne MW; Langeveld TPM; Veselic M; van Benthem PPG; Sjögren EV
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2333-2340. PubMed ID: 30027440
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of age, subglottic, and anterior commissure involvement for early glottic carcinoma treated with CO
Carta F; Bandino F; Olla AM; Chuchueva N; Gerosa C; Puxeddu R
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1199-1210. PubMed ID: 29442166
[TBL] [Abstract][Full Text] [Related]
7. Transoral Laser Microsurgery for Glottic Cancer in Patients Over 75 Years Old.
Paderno A; Lancini D; Bosio P; Del Bon F; Fior M; Berretti G; Alparone M; Deganello A; Peretti G; Piazza C
Laryngoscope; 2022 Jan; 132(1):135-141. PubMed ID: 34233029
[TBL] [Abstract][Full Text] [Related]
8. Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes.
Warner L; Lee K; Homer JJ
Clin Otolaryngol; 2017 Jun; 42(3):629-636. PubMed ID: 27863075
[TBL] [Abstract][Full Text] [Related]
9. Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with trans-oral CO2 laser microsurgery.
Hakeem AH; Tubachi J; Pradhan SA
Laryngoscope; 2013 Aug; 123(8):1912-7. PubMed ID: 23606304
[TBL] [Abstract][Full Text] [Related]
10. Transoral laser microsurgery for early glottic cancer as one-stage single-modality therapy.
Lee HS; Chun BG; Kim SW; Kim ST; Oh JH; Hong JC; Lee KD
Laryngoscope; 2013 Nov; 123(11):2670-4. PubMed ID: 23553229
[TBL] [Abstract][Full Text] [Related]
11. Laser Microsurgery Versus Radiotherapy Versus Open Partial Laryngectomy for T2 Laryngeal Carcinoma: A Systematic Review of Oncological Outcomes.
Campo F; Zocchi J; Ralli M; De Seta D; Russo FY; Angeletti D; Minni A; Greco A; Pellini R; de Vincentiis M
Ear Nose Throat J; 2021 Feb; 100(1_suppl):51S-58S. PubMed ID: 32511005
[TBL] [Abstract][Full Text] [Related]
12. Transoral laser microsurgery for T1a glottic cancer: review of 404 cases.
Canis M; Ihler F; Martin A; Matthias C; Steiner W
Head Neck; 2015 Jun; 37(6):889-95. PubMed ID: 24623709
[TBL] [Abstract][Full Text] [Related]
13. Long-term swallowing outcomes of radiotherapy and transoral laser microsurgery for T1 glottic cancer treatment.
Ozturk K; Turhal G; Durusoy D; Sahin E; Akagunduz O; Eyigor S; Akyildiz S; Esassolak M
Clin Otolaryngol; 2021 Mar; 46(2):340-346. PubMed ID: 33248015
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for local recurrence of early bilateral vocal cord carcinoma treated with transoral CO
Tan C; Fang J; Wang R; Zhong Q; Hou L; Ma H; Feng L; He S; Lian M; Yang Y
Acta Otolaryngol; 2021 Sep; 141(9):860-864. PubMed ID: 34565304
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between transoral microsurgery by CO2 laser and conventional surgical therapy for T2 glottic carcinoma].
Kehrl W; Tolkemitt J; Düsterhus P
Laryngorhinootologie; 2003 Mar; 82(3):189-94. PubMed ID: 12673518
[TBL] [Abstract][Full Text] [Related]
16. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.
Wilkie MD; Lightbody KA; Pinto R; Tandon S; Jones TM; Lancaster J
Clin Otolaryngol; 2015 Dec; 40(6):610-5. PubMed ID: 25816841
[TBL] [Abstract][Full Text] [Related]
18. Transoral laser microsurgery for T1b glottic cancer: review of 51 cases.
Weiss BG; Ihler F; Pilavakis Y; Wolff HA; Canis M; Welz C; Steiner W
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1997-2004. PubMed ID: 28028607
[TBL] [Abstract][Full Text] [Related]
19. Oncological and functional outcomes following transoral laser microsurgery in patients with T2a vs T2b glottic squamous cell carcinoma.
Forner D; Rigby MH; Hart RD; Trites JR; Taylor SM
J Otolaryngol Head Neck Surg; 2019 Jun; 48(1):27. PubMed ID: 31174618
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.
Gioacchini FM; Tulli M; Kaleci S; Bondi S; Bussi M; Re M
Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4091-4102. PubMed ID: 28929221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
